| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/13/2013 | CN101213297B Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics |
| 02/12/2013 | US8372961 Polynucleotides encoding concatameric immunoadhesion molecules |
| 02/12/2013 | US8372959 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 02/12/2013 | US8372958 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 02/12/2013 | US8372957 Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved |
| 02/12/2013 | US8372956 Antibodies produced in a transgenic avian egg white |
| 02/12/2013 | US8372955 Purified antibody to the extracellular domain of NKp44L |
| 02/12/2013 | US8372954 Pool of variable heavy chain immunoglobulins comprised of framework v region domains; single heavy domain antibody fragments; immmunodiagnostics |
| 02/12/2013 | US8372800 Albumin-free factor VIII formulations |
| 02/12/2013 | US8372639 Anti-human α9 integrin antibody and use thereof |
| 02/12/2013 | US8372625 Polynucleotides encoding antagonist antibodies against GDF-8 |
| 02/12/2013 | US8372605 Immuno-amplification |
| 02/12/2013 | US8372410 S. epidermidis antigens |
| 02/12/2013 | US8372404 Anti-C5/C5a antibodies and methods of use |
| 02/12/2013 | US8372403 Humanized anti-factor D antibodies and uses thereof |
| 02/12/2013 | US8372402 Mammalian receptor proteins DCRS5; methods of treatment |
| 02/12/2013 | US8372401 Human antibodies that bind human TNFα |
| 02/12/2013 | US8372400 Methods of treating disorders using human antibodies that bind human TNFα |
| 02/12/2013 | CA2665707C Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum |
| 02/12/2013 | CA2506890C Method for isolating intracellular antibodies able to neutralize protein interactions |
| 02/12/2013 | CA2498058C N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses |
| 02/12/2013 | CA2493471C Compounds binding to p-selectin |
| 02/12/2013 | CA2469715C Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 02/12/2013 | CA2388450C Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 02/12/2013 | CA2345817C Novel methods for therapeutic vaccination |
| 02/12/2013 | CA2336250C Anti-ccr2 antibodies and methods of use therefor |
| 02/12/2013 | CA2274490C Non-m non-o hiv strains, fragments and applications |
| 02/07/2013 | WO2013020090A2 STREPTOCOCCAL GLcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM |
| 02/07/2013 | WO2013019954A1 Method for treating bone gap defects |
| 02/07/2013 | WO2013019906A1 Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors |
| 02/07/2013 | WO2013019889A2 Bovine polyclonal antibody specific for human tnf |
| 02/07/2013 | WO2013019730A1 Antibodies to tip-1 and grp78 |
| 02/07/2013 | WO2013018894A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | WO2013018892A1 Drug composition for cancer treatment and/or prevention |
| 02/07/2013 | WO2013018891A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | WO2013018889A1 Cancer treatment and/or prevention drug composition |
| 02/07/2013 | WO2013018885A1 Method for detecting pancreatic cancer |
| 02/07/2013 | WO2013018883A1 Cancer treatment and/or prevention drug composition |
| 02/07/2013 | WO2013018882A1 Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene |
| 02/07/2013 | WO2013018866A1 Method for assessing myelodysplastic syndrome or myeloid tumor predisposition, polypeptide and antibody therefor, and candidate screening method for therapeutic drug or prophylactic drug therefor |
| 02/07/2013 | WO2013017891A2 Assay |
| 02/07/2013 | WO2013017830A1 Leptin receptor structure |
| 02/07/2013 | WO2013017713A1 Hrsv f protein in the stabilised pre-fusion state and specific neutralising antibodies against same |
| 02/07/2013 | WO2013017691A1 Cahgt1p inhibitors for use in the treatment of candidiasis |
| 02/07/2013 | WO2013017566A1 Novel anti-cxcr4 antibody and its use for the detection and diagnosis of cancer |
| 02/07/2013 | WO2013017562A1 Use of the antibody i-3859 for the detection and diagnosis of cancer |
| 02/07/2013 | WO2013017540A1 Combination therapy for the treatment of cd19+ b-cell malignancies symptoms comprising an anti-cd19 maytansinoid immunoconjugate and rituximab |
| 02/07/2013 | WO2012125652A3 Antibody and antibody mimetic for visualization and ablation of endogenous proteins |
| 02/07/2013 | WO2011106297A3 Compositions and methods for the diagnosis and treatment of tumor |
| 02/07/2013 | US20130036517 Intein-modified enzymes, their production and industrial applications |
| 02/07/2013 | US20130035476 Crystal structure of staphylococcus aureus clumping factor a in complex with fibrinogen derived peptide and uses thereof |
| 02/07/2013 | US20130035475 Methods for Identifying Compounds That Modulate Ion Channel Activity of a Kir Channel |
| 02/07/2013 | US20130035293 Compositions and methods for modulating dopamine neurotransmission |
| 02/07/2013 | US20130035287 Transient immortalization |
| 02/07/2013 | US20130035260 Genes involved in inflammatory bowel diseases and use thereof |
| 02/07/2013 | US20130034890 Polypeptides Having Cellobiohydrolase 1 Activity and Polynucleotides Encoding Same |
| 02/07/2013 | US20130034849 Diagnosis of hereditary spastic paraplegias (hsp) by detection of a mutation in the kiaa1840 gene or protein |
| 02/07/2013 | US20130034576 Novel adenovirus isolated from titi monkeys |
| 02/07/2013 | US20130034575 Method for identification, isolation and production of antigens to a specific pathogen |
| 02/07/2013 | US20130034566 Anti-cdh3 antibodies and uses thereof |
| 02/07/2013 | US20130034565 MOLECULES AND METHODS OF USING SAME FOR TREATING ErbB/ErbB LIGANDS ASSOCIATED DISEASES |
| 02/07/2013 | US20130034564 Anti-rsv g protein antibodies |
| 02/07/2013 | US20130034561 Isolated mammalian monocyte cell genes; related reagents |
| 02/07/2013 | US20130034560 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 02/07/2013 | US20130034559 Targeted Binding Agents Against B7-H1 |
| 02/07/2013 | US20130034558 Epidermal growth factor receptor variant |
| 02/07/2013 | US20130034557 Cancer-Related Glycopeptide Epitopes, Antibodies And Methods Of Use |
| 02/07/2013 | US20130034556 Free hexasaccharide isolated from several campylobacter species |
| 02/07/2013 | US20130034553 Fusion Polypeptides Capable of Activating Receptors |
| 02/07/2013 | US20130034547 Reliable stabilization of n-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns |
| 02/07/2013 | US20130034499 Sgii as a prognostic marker in conditions which require critical care |
| 02/07/2013 | CA2848369A1 Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene |
| 02/07/2013 | CA2844042A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844040A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844038A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844034A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844033A1 Method for detecting pancreatic cancer |
| 02/07/2013 | CA2844030A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2843595A1 Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors |
| 02/07/2013 | CA2843315A1 Bovine polyclonal antibody specific for human tnf |
| 02/07/2013 | CA2842552A1 Use of the antibody i-3859 for the detection and diagnosis of cancer |
| 02/07/2013 | CA2842513A1 Novel anti - cxcr4 antibody and its use for the detection and diagnosis of cancer |
| 02/07/2013 | CA2842432A1 Method for treating bone gap defects |
| 02/06/2013 | EP2554993A1 Marker for diagnosing effect of anticancer agent |
| 02/06/2013 | EP2554673A1 Novel monoclonal antibody and method for immunoassaying d dimer |
| 02/06/2013 | EP2554669A1 Novel antibody having modification site introduced therein, and antibody fragment |
| 02/06/2013 | EP2554552A1 Novel anti-cd98 antibody and use thereof |
| 02/06/2013 | EP2554160A1 Method for preparing an enriched IgG composition from plasma |
| 02/06/2013 | EP2553452A1 Detection of feline immunodeficiency virus |
| 02/06/2013 | EP2553150A1 Generation of antibodies to an epitope of interest |
| 02/06/2013 | EP2553100A2 Genetic engineering of non-human animals for the production of chimeric antibodies |
| 02/06/2013 | EP2552967A2 Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same |
| 02/06/2013 | EP2552966A1 Antibodies against csf-1r |
| 02/06/2013 | EP2552965A2 Anti-cd40 antibodies |
| 02/06/2013 | EP2552964A1 CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |
| 02/06/2013 | EP2552963A1 Humanized anti cxcr4 antibodies for the treatment of cancer |
| 02/06/2013 | EP2552962A1 Immunoglobulin single variable domains directed against cxcr7 |
| 02/06/2013 | EP2552961A1 Humanized il-25 antibodies |
| 02/06/2013 | EP2552960A1 Bispecific, bivalent anti-vegf/anti-ang-2 antibodies |
| 02/06/2013 | EP2552959A2 Antibodies to muc16 and methods of use thereof |